Frontlight ResearchEarly access
Active, not recruitingNo phase
Proteomic Analysis on Myopic Children Using Orthokeratology Lenses With Good or Poor Myopic Control
Key facts
- Who runs it
- Vejle Hospital
- Where
- Denmark1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 20 people enrolled
- Started
- 15 Nov 2024
- Expected to end
- Dec 2026
- Type of study
- Observational
- Record updated
- 21 July 2026
Who can take part
- Age
- 5 years to 14 years
- Sex
- Women and men
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Children treated with orthokeratology lenses
- Children on or above the 95th percentile of myopia growth curves for European children at the time of treatment initiation
- Treatment and follow-up duration ≥ 6 months
Who cannot take part
- Active eye infection
- Current use of eye drops
- Objective signs of dry eyes on slit-lamp examination
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The key objective of the study is to gain an understanding of the biochemical processes that contribute to orthokeratology lenses being more effective in specific individuals compared to others. With this knowledge, we hope to optimize treatment effectiveness in those currently experiencing less favorable outcomes from treatment in the future.
Read full original descriptionShow less
The primary aim is to investigate differences in protein levels in children using orthokeratology lenses with various effects of myopia control.
Hypothesis: There is a significant difference in the expression of molecules in children with various effects of myopia control.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Proteomic Analysis on Myopic Children Using Orthokeratology Lenses With Good or Poor Myopic Control. The ProMOC Study
- Record updated
- 21 July 2026